Recent Study: Sri Lanka Pharmaceuticals & Healthcare Report Q1 2014
The outlook for Sri Lanka's pharmaceutical and healthcare has slipped since the update last quarter, which we believe is largely due to a weaker-than-expected economic performance that is feeding through to the healthcare sector. While we are encouraged by the government's focus on increasing local production of medicines, both on a national level and by inviting foreign investment, in January 2014, the government is likely to implement price controls on the pharmaceutical industry, which is likely to be detrimental to...
View full press release